References
- Adu-Gyamfi, E. A., J. Lamptey, F. Duan, Y. X. Wang, and Y. B. Ding. 2019. The transforming growth factor β superfamily as possible biomarkers of preeclampsia: A comprehensive review. Biomarkers in Medicine 13:1321–30. doi:https://doi.org/10.2217/bmm-2019-0208.
- Appiah Adu-Gyamfi, E., F. Tanam Djankpa, W. Nelson, A. Czika, S. Kumar Sah, J. Lamptey, Y. B. Ding, and Y. X. Wang. 2020. Activin and inhibin signaling: From regulation of physiology to involvement in the pathology of the female reproductive system. Cytokine 133:155105. doi:https://doi.org/10.1016/j.cyto.2020.155105.
- Bayne, R. A., S. L. Eddie, C. S. Collins, A. J. Childs, H. N. Jabbour, and R. A. Anderson. 2009. Prostaglandin E2 as a regulator of germ cells during ovarian development. The Journal of Clinical Endocrinology and Metabolism 94:4053–60. doi:https://doi.org/10.1210/jc.2009-0755.
- Bearfield, C., E. Jauniaux, N. Groome, I. L. Sargent, and S. Muttukrishna. 2005. The secretion and effect of inhibin A, activin A and follistatin on first-trimester trophoblasts in vitro. European Journal of endocrinology/European Federation of Endocrine Societies 152:909–16. doi:https://doi.org/10.1530/eje.1.01928.
- Bloise, E., P. Ciarmela, C. Dela Cruz, S. Luisi, F. Petraglia, and F. M. Reis. 2019. Activin A in mammalian physiology. Physiological Reviews 99:739–80. doi:https://doi.org/10.1152/physrev.00002.2018.
- Brosens, I., R. Pijnenborg, L. Vercruysse, and R. Romero. 2011. The “Great obstetrical syndromes” are associated with disorders of deep placentation. American Journal of Obstetrics and Gynecology 204:193–201. doi:https://doi.org/10.1016/j.ajog.2010.08.009.
- Cuello, J. P., M. L. Martínez Ginés, A. Tejeda-Velarde, S. Medina Heras, J. M. García Domínguez, J. I. Fernández Velasco, A. Lozano Ros, Y. Higueras, A. Meldaña Rivera, H. Goicochea Briceño, et al. 2020. Cytokine profile during pregnancy predicts relapses during pregnancy and postpartum in multiple sclerosis. Journal of the Neurological Sciences 414:116811. doi:https://doi.org/10.1016/j.jns.2020.116811.
- D’Antona, D., F. M. Reis, C. Benedetto, L. W. Evans, N. P. Groome, D. M. De Kretser, E. M. Wallace, and F. Petraglia. 2000. Increased maternal serum activin A but not follistatin levels in pregnant women with hypertensive disorders. The Journal of Endocrinology 165:157–62. doi:https://doi.org/10.1677/joe.0.1650157.
- Diesch, C. H., W. Holzgreve, S. Hahn, and X. Y. Zhong. 2006. Comparison of activin A and cell-free fetal DNA levels in maternal plasma from patients at high risk for preeclampsia. Prenatal Diagnosis 26:1267–70. doi:https://doi.org/10.1002/pd.1606.
- Goldman-Wohl, D., M. Gamliel, O. Mandelboim, and S. Yagel. 2019. Learning from experience: Cellular and molecular bases for improved outcome in subsequent pregnancies. American Journal of Obstetrics and Gynecology 221:183–93. doi:https://doi.org/10.1016/j.ajog.2019.02.037.
- Guo, H. X., Y. B. Zhu, C. P. Wu, M. Zhong, and S. W. Hu. 2019. Potential urine biomarkers for gestational hypertension and preeclampsia. Molecular Medicine Reports 19:2463–70. doi:https://doi.org/10.3892/mmr.2019.9911.
- Hao, S., J. You, L. Chen, H. Zhao, Y. Huang, L. Zheng, L. Tian, I. Maric, X. Liu, T. Li, et al. 2020. Changes in pregnancy-related serum biomarkers early in gestation are associated with later development of preeclampsia. PloS One 15:e0230000. doi:https://doi.org/10.1371/journal.pone.0230000.
- Lai, J., A. Pinas, A. Syngelaki, L. C. Poon, and K. H. Nicolaides. 2013. Maternal serum activin-A at 30-33 weeks in the prediction of preeclampsia. The Journal of Maternal-fetal & Neonatal Medicine: The Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstet 26:733–37. doi:https://doi.org/10.3109/14767058.2012.755167.
- Lecarpentier, E., J. C. Gris, E. Cochery-Nouvellon, E. Mercier, H. Abbas, R. Thadhani, S. A. Karumanchi, and B. Haddad. 2019. Urinary placental growth factor for prediction of placental adverse outcomes in high-risk pregnancies. Obstetrics and Gynecology 134:1326–32. doi:https://doi.org/10.1097/aog.0000000000003547.
- Li, L., Y. Zheng, Y. Zhu, and J. Li. 2016. Serum biomarkers combined with uterine artery doppler in prediction of preeclampsia. Experimental and Therapeutic Medicine 12:2515–20. doi:https://doi.org/10.3892/etm.2016.3625.
- O’Connor, A. E., J. R. McFarlane, S. Hayward, T. Yohkaichiya, N. P. Groome, and D. M. De Kretser. 1999. Serum activin A and follistatin concentrations during human pregnancy: A cross-sectional and longitudinal study. Human Reproduction (Oxford, England) 14:827–32. doi:https://doi.org/10.1093/humrep/14.3.827.
- Refaat, B., and A. O. Bahathiq. 2020. The performances of serum activins and follistatin in the diagnosis of ectopic pregnancy: A prospective case-control study. Clinica Chimica Acta; International Journal of Clinical Chemistry 500:69–74. doi:https://doi.org/10.1016/j.cca.2019.09.019.
- Rosenberg, V. A., I. A. Buhimschi, A. T. Dulay, S. S. Abdel-Razeq, E. A. Oliver, C. M. Duzyj, H. Lipkind, C. M. Pettker, and C. S. Buhimschi. 2012. Modulation of amniotic fluid activin-a and inhibin-a in women with preterm premature rupture of the membranes and infection-induced preterm birth. American Journal of Reproductive Immunology (New York, N.Y.: 1989) 67:122–31. doi:https://doi.org/10.1111/j.1600-0897.2011.01074.x.
- Shah, P. S. 2010. Parity and low birth weight and preterm birth: A systematic review and meta-analyses. Acta obstetricia et gynecologica Scandinavica 89:862–75. doi:https://doi.org/10.3109/00016349.2010.486827.
- Spencer, K., N. J. Cowans, and K. H. Nicolaides. 2008. Maternal serum inhibin-A and activin-A levels in the first trimester of pregnancies developing pre-eclampsia. Ultrasound in Obstetrics & Gynecology: The Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology 32:622–26. doi:https://doi.org/10.1002/uog.6212.
- Tuuri, T., M. Eramaa, K. Hilden, and O. Ritvos. 1994. The tissue distribution of activin beta A- and beta B-subunit and follistatin messenger ribonucleic acids suggests multiple sites of action for the activin-follistatin system during human development. The Journal of Clinical Endocrinology and Metabolism 78:1521–24. doi:https://doi.org/10.1210/jcem.78.6.8200957.
- Zen, M., S. Padmanabhan, K. Zhang, A. Kirby, N. W. Cheung, V. W. Lee, and T. I. Alahakoon. 2020. Urinary and serum angiogenic markers in women with preexisting diabetes during pregnancy and their role in preeclampsia prediction. Diabetes Care 43:67–73. doi:https://doi.org/10.2337/dc19-0967.
- Zhu, S., Z. Li, L. Cui, Y. Ban, P. C. K. Leung, Y. Li, and J. Ma. 2020. Activin A increases human trophoblast invasion by upregulating integrin β1 through ALK4. FASEB Journal: Official Publication of the Federation of American Societies for Experimental Biology. doi:https://doi.org/10.1096/fj.202001604R.